Management of ovarian hyperstimulation syndrome. Produced on behalf of the BFS policy and practice committee

Human Fertility

Volumn 16, Issue 3, 2013, Pages 151-159

  Tan, Bee Kang ^a,b   Mathur, Raj ^a,b  

^a Cambridge IVF   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; CODEINE; CYCLIZINE; GONADORELIN ANTAGONIST; METOCLOPRAMIDE; PARACETAMOL; PROCHLORPERAZINE; PROGESTERONE;

ADULT RESPIRATORY DISTRESS SYNDROME; ANALGESIA; ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; CRYOPRESERVATION; DISEASE SEVERITY; DRUG CONTRAINDICATION; FERTILIZATION IN VITRO; HEALTH CARE POLICY; HIGH RISK POPULATION; MORBIDITY; MORTALITY; NAUSEA AND VOMITING; OVARY HYPERSTIMULATION; PAIN; PARACENTESIS; PATHOGENESIS; SYNDROME; TREATMENT PLANNING;

EVIDENCE-BASED MEDICINE; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; HUMANS; INFERTILITY, FEMALE; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; PRACTICE GUIDELINES AS TOPIC; SEVERITY OF ILLNESS INDEX;

EID: 84884581583     PISSN: 14647273     EISSN: 17428149     Source Type: Journal    
DOI: 10.3109/14647273.2013.788313     Document Type: Article

References (79)

1. Aboulghar, M.A., Mansour, R.T., Serour, G.I., & Amin, Y. (1990). Ultrasonically guided vaginal aspiration of ascites in the treatment of severe ovarian hyperstimulation syndrome. Fertility and Sterility, 53, 933-935. (Pubitemid 20180489)
2. Abramov, Y., Barak, V., Nisman, B., & Schenker, J.G. (1997). Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertility and Sterility, 67, 261-265. (Pubitemid 27052182)
3. Abramov, Y., Elchalal, U., & Schenker, J.G. (1998). Obstetric outcome of in vitro fertilized pregnancies complicated by severe ovarian hyperstimulation syndrome: a multicenter study. Fertility and Sterility, 70, 1070-1076. (Pubitemid 28546233)
4. Abramov, Y., Elchalal, U., & Schenker, J.G. (1999a). Pulmonary manifestations of severe ovarian hyperstimulation syndrome: a multicenter study. Fertility and Sterility, 71, 645-651. (Pubitemid 29149413)
5. Abramov, Y., Elchalal, U., & Schenker, J.G. (1999b). An ' epidemic ' of severe OHSS-a price we have to pay Human Reproduction, 14, 2181-2183. (Pubitemid 29425394)
6. Abramov, Y., Fatum, M., Abrahamov, D., & Schenker, J.G. (2001). Hydroxyethylstarch versus human albumin for the treatment of severe ovarian hyperstimulation syndrome: a preliminary report. Fertility and Sterility, 75, 1228-1230. (Pubitemid 32522627)
7. Abuzeid, M.I., Nassar, Z., Massaad, Z., Weiss, M., Ashraf, M., & Fakih, M. (2003). Pigtail catheter for the treatment of ascites associated with ovarian hyperstimulation syndrome. Human Reproduction, 18, 370-373. (Pubitemid 36236273)
8. Al-Ramahi, M., Leader, A., Claman, P., & Spence, J. (1997). A novel approach to the treatment of ascites associated with ovarian hyperstimulation syndrome. Human Reproduction, 12, 2614-2616. (Pubitemid 28031718)
9. Ando, H., Furugori, K., Shibata, D., Harata, T., Murata, Y., & Mizutani, S. (2003). Dual renin-angiotensin blockade therapy in patients at high risk of early ovarian hyperstimulation syndrome receiving IVF and elective embryo cryopreservation: a case series. Human Reproduction, 18, 1219-1222. (Pubitemid 36740567)
10. Ata, B., Yakin, K., Alatas, C., & Urman, B. (2008). Dual renin-angiotensin blockage and total embryo cryopreservation is not a risk-free strategy in patients at high risk for ovarian hyperstimulation syndrome. Fertility and Sterility, 90, 531-536.
11. Ayus, J.C., Krothapalli, R.K., & Arieff, A.I. (1987). Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study. New England Journal of Medicine, 317, 1190-1195. (Pubitemid 17150331)
12. Balasch, J., Carmona, F., Llach, J., Arroyo, V., Jove, I., & Vanrell, J.A. (1990). Acute prerenal failure and liver dysfunction in a patient with severe ovarian hyperstimulation syndrome. Human Reproduction, 5, 348-351. (Pubitemid 20253458)
13. Bates, S.M., Greer, I.A., Middledorp, S., Veenstra, D.L., Prabulos, A.-M., & Vandvik, P.O. (2012). VTE, thrombophilia, antithrombotic therapy and prevention of thrombosis: Americal College of Chest Physicians Evidence-based clinical practice guidelines. Chest, 141, e691S-e736S.
14. Braat, D.D.M., Schutte, J.M., Bernardus, R.E., Mooij, T.M., & van Leeuwen, F.E. (2010). Maternal death related to IVF in the Netherlands 1984-2008. Human Reproduction, 25, 1782-1786.
15. Cheatham, M.L. (2009). Abdominal compartment syndrome. Current Opinion in Critical Care, 15, 154-162.
16. Chen, C.D., Yang, J.H., Chao, K.H., Chen, S.U., Ho, H.N., & Yang, Y.S. (1998). Eff ects of repeated abdominal paracentesis on uterine and intraovarian haemodynamics and pregnancy outcome in severe ovarian hyperstimulation syndrome. Human Reproduction, 13, 2077-2081.
17. Cil, T., Tummon, I.S., House, A.A., Taylor, B., Hooke, G., Franklin, J., et al. (2000). A tale of two syndromes: ovarian hyperstimulation and abdominal compartment. Human Reproduction, 15, 1058-1060. (Pubitemid 30251299)
18. Csokmay, J.M., Yauger, B.J., Henne, M.B., Armstrong, A.Y., Queenan, J.T., & Segars, J.H. (2010). Cost analysis model of outpatient management of ovarian hyperstimulation syndrome with paracentesis: " Tap early and often " versus hospitalization. Fertility and Sterility, 93, 167-173.
19. Delbaere, A., Smits, G., De Leener, A., Costagliola, S., & Vassart, G. (2005). Understanding ovarian hyperstimulation syndrome. Endocrine, 26, 285-290.
20. Delvigne, A., Demoulin, A., Smitz, J., Donnez, J., Koinckx, P., Dhont, M., Englert, Y., Delbeke, L., Darcis, L., Gordts, S., et al. (1993). Th e ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features. Human Reproduction, 8, 1353-1360. (Pubitemid 23265961)
21. Delvigne, A. & Rosenberg S. (2003). Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Human Reproduction Update, 9, 77-96. (Pubitemid 36305585)
22. Delvigne, A. & Rozenberg, S. (2002). Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Human Reproduction Update, 8, 559-577. (Pubitemid 35452781)
23. Derkx, F.H., Alberda, A.T., Zeilmaker, G.H., & Schalekamp, M.A. (1987). High concentrations of immunoreactive renin, prorenin and enzymatically-active renin in human ovarian follicular fl uid. British Journal of Obstetrics and Gynaecology, 94, 4-9. (Pubitemid 17027521)
24. Enskog, A., Henriksson, M., Unander, M., Nilsson, L., & Brannstrom, M. (1999). Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization. Fertility and Sterility, 71, 808-814. (Pubitemid 29206902)
25. Evbuomwan, I.O., Davison, J.M., & Murdoch, A.P. (2000). Coexistent hemoconcentration and hypoosmolality during superovulation and in severe ovarian hyperstimulation syndrome: a volume homeostasis paradox. Fertility and Sterility, 74, 67-72. (Pubitemid 30427275)
26. Fabregues, F., Balasch, J., Ginès, P., Manau, D., Jiménez, W., Arroyo, V., et al. (1999). Ascites and liver test abnormalities during severe ovarian hyperstimulation syndrome. American Journal of Gastroenterology, 94, 994-999. (Pubitemid 29173617)
27. Ferrara, N. & Davis-Smyth, T. (1997). Th e biology of vascular endothelial growth factor. Endocrine Reviews, 18, 4-25. (Pubitemid 27076453)
28. Ferrareti, A.P., Gianaroli, L., Diotallevi, L., Festi, C., & Trounson, A. (1992). Dopamine treatment for severe ovarian hyperstimulation syndrome. Human Reproduction, 7, 180-183.
29. Fluker, M.R., Copeland, J.E., & Yuzpe, A.A. (2000). An ounce of prevention: outpatient management of the ovarian hyperstimulation syndrome. Fertility and Sterility, 73, 821-824. (Pubitemid 30154125)
30. Geva, E. & Jaff e, R.B. (2000). Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertility and Sterility, 74, 429-438.
31. Golan, A. & Weissman, A. (2009). A modern classifi cation of OHSS. Reproductive Biomedicine Online, 19, 28-32.
32. Goldsman, M.P., Pedram, A., Dominguez, C.E., Ciuff ardi, I., Levin, E., & Asch, R.H. (1995). Increased capillary permeability induced by human follicular fl uid: a hypothesis for an ovarian origin of the hyperstimulation syndrome. Fertility and Sterility, 63, 268-272.
33. Gordon, J.D., Hopkins, K.L., Jeff rey, R.B., & Giudice, L.C. (1994). Adnexal torsion: color Doppler diagnosis and laparoscopic treatment. Fertility and Sterility, 61, 383-385. (Pubitemid 24057279)
34. Gorkemli, H., Camus, M., & Clasen, K. (2002). Adnexal torsion after gonadotrophin ovulation induction for IVF or ICSI and its conservative treatment. Archives of Gynecology and Obstetrics, 267, 4-6. (Pubitemid 36998763)
35. Grossman, L.C., Michalakis, K.G., Browne, H., Payson, M.D., & Segars, J.H. (2010). Th e pathophysiology of ovarian hyperstimulation syndrome: an unrecognized compartment syndrome . Fertility and Sterility, 94, 1392-1398.
36. Hew-Butler, T., Almond, C., Ayus, J.C., Dugas, J., Meeuwisse, W., Noakes, T., et al.; Exercise-Associated Hyponatremia (EAH) Consensus Panel. (2005). Consensus statement of the 1st International Exercise-Associated Hyponatremia Consensus Development Conference, Cape Town, South Africa 2005. Clinical Journal of Sport Medicine, 15, 208-213.
37. HFEA. (2008). A long-term analysis of the HFEA register data 1991-2006 Version 1 Revision 4, Extract date 23/01/2008 http://www.hfea.gov. uk/docs/Latest-long-term-data-analysis-report-91-06.pdf.pdf.
38. Hitkari, J.A., Rowe, T.P., & von Dadelszen, P. (2006). Activated protein C and the ovarian hyperstimulation syndrome: possible therapeutic implications. Medical Hypotheses, 66, 929-933. (Pubitemid 43207648)
39. Koninckx, P.R., Renaer, M., & Brosens, I.A. (1980). Origin of peritoneal fl uid in women: an ovarian exudation product. British Journal of Obstetrics and Gynaecology, 87, 177-183. (Pubitemid 10153694)
40. Lainas, T.G., Sfontouris, I.A., Zorzovilis, I.Z., Petsas, G.K., Lainas, G.T., Iliadis, G.S., & Kolibianakis, E.M. (2009). Management of severe OHSS using GnRH antagonist and blastocyst cryopreservation in PCOS patients treated with long protocol. Reproductive Biomedicine Online, 18, 15-20.
41. Levin, I., Almog, B., Avni, A., Baram, A., Lessing, J.B., & Gamzu, R. (2002). Eff ect of paracentesis of ascitic fl uids on urinary output and blood indices in patients with severe ovarian hyperstimulation syndrome. Fertility and Sterility, 77, 986-988. (Pubitemid 34497167)
42. Lincoln, S.R., Opsahl, M.S., Blauer, K.L., Black, S.H., & Schulman, J.D. (2002). Aggressive outpatient treatment of ovarian hyper stimulation syndrome with ascites using transvaginal culdocentesis and intravenous albumin minimizes hospitalization. Journal of Assisted Reproduction and Genetics, 19, 159-163. (Pubitemid 34522445)
43. Ludwig, M., Bauer, O., Lopens, A., Jelkmann, W., & Diedrich, K. (1998). Serum concentrations of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation. Human Reproduction, 13, 30-32. (Pubitemid 28075267)
44. Malbrain, M., Cheatham, M., Kirkpatrick, A., Sugrue, M., Parr, M., De Waele, J., et al. (2006). Results from the international conference of experts on intra-abdominal hypertension and abdominal compartment syndrome. I. Defi nitions. Intensive Care Medicine, 32, 1722-1732. (Pubitemid 44607359)
45. Manno, M. & Tomei, F. (2008). Renin-angiotensin system activation during severe OHSS: cause or eff ect Fertility and Sterility, 89, 488. (Pubitemid 351217076)
46. Mashiach, S., Bider, D., Moran, O., Goldenberg, M., & Ben-Rafael, Z. (1990). Adnexal torsion of hyperstimulated ovaries in pregnancies after gonadotropin therapy. Fertility and Sterility, 53, 76-80. (Pubitemid 20041319)
47. Maslovitz, S., Jaff a, A., Eytan, O., Wolman, I., Many, A., Lessing, J.B., & Gamzu, R. (2004). Renal blood fl ow alteration after paracentesis in women with ovarian hyperstimulation. Obstetrics & Gynecology, 104, 321-326. (Pubitemid 40458879)
48. Mathur, R.S. & Jenkins, J.M. (2009). Towards a clinically useful classifi cation of OHSS. Reproductive Biomedicine Online, 19, 434.
49. Mathur, R.S., Akande, A.V., Keay, S.D., Hunt, L.P., & Jenkins, J.M. (2000). Distinction between early and late ovarian hyperstimulation syndrome. Fertility and Sterility, 73, 901-907. (Pubitemid 30227512)
50. Mathur, R., Evbuomwan, I., & Jenkins, J. (2005). Prevention and management of ovarian hyperstimulation syndrome. Current Obstetrics & Gynaecology, 15, 132-138. (Pubitemid 40386365)
51. Mathur, R., Hayman, G., Bansal, A., & Jenkins, J. (2002). Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception. Fertility and Sterility, 78, 1154-1158. (Pubitemid 35463106)
52. McClure, N., Healy, D.L., Rogers, P.A., Sullivan, J., Beaton, L., Haning, R.V. Jr., et al. (1994). Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet, 344, 235-236. (Pubitemid 24229013)
53. Morris, R.S., Miller, C., Jacobs, L., & Miller, K. (1995). Conservative management of ovarian hyperstimulation syndrome. Journal of Reproductive Medicine, 40, 711-714.
54. Navot, D., Bergh, P.A., & Laufer, N. (1992). Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertility and Sterility, 58, 249-261.
55. Navot, D., Margalioth, E.J., Laufer, N., Birkenfeld, A., Relou, A., Rosler, A., & Schenker, J.G. (1987). Direct correlation between plasma renin activity and severity of the ovarian hyperstimulation syndrome. Fertility and Sterility, 48, 57-61. (Pubitemid 17093253)
56. Neulen, J., Yan, Z., Raczek, S., Weindel, K., Keek, C., Weich, H.A., et al. (1995). Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. Journal of Clinical Endocrinology & Metabolism, 80, 1967-1971.
57. Oelsner, G., Cohen, S.B., Soriano, D., Admon, D., Mashiach, S., & Carp, H. (2003). Minimal surgery for the twisted ischaemic adnexa can preserve ovarian function. Human Reproduction, 18, 2599-2602. (Pubitemid 37536626)
58. Ozgun, M.T., Batukan, C., Oner, G., Uludag, S., Aygen, E.M., & Sahin, Y. (2008). Removal of ascites up to 7.5 liters on one occasion and 45 liters in total may be safe in patients with severe ovarian hyperstimulation syndrome. Gynecological Endocrinology, 24, 656-658.
59. Pellicer, A., Albert, C., Mercader, A., Bonilla-Musoles, F., Remohi, J., & Simon, C. (1999). Th e pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1b, interleukin-6, and vascular endothelial growth factor. Fertility and Sterility, 71, 482-489. (Pubitemid 29094125)
60. Pellicer, A., Miro, F., Sampaio, M., Gomez, E., & Bonilla-Musoles, F.M. (1991). In vitro fertilization as a diagnostic and therapeutic tool in a patient with partial 17, 20-desmolase defi ciency. Fertility and Sterility, 55, 970-975.
61. Pietrowski, D., Szabo, L., Sator, M., Just, A., & Egarter, C. (2011). Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A. Human Reproduction, 27, 196-199.doi:10.1093/humrep/der349.
62. Reed, A.P., Tausk, H., & Reynolds, H. (1990). Anesthetic considerations for severe ovarian hyperstimulation syndrome. Anesthesiology, 73, 1275-1277.
63. Rinaldi, M.L. & Spirtos, N.J. (1995). Chest tube drainage of pleural eff usion correcting abdominal ascites in a patient with severe ovarian hyperstimulation syndrome: a case report. Fertility and Sterility, 63, 1114-1117.
64. Rizk, B. & Aboulghar, M. (1991). Modern management of ovarian hyperstimulation syndrome. Human Reproduction, 6, 1082-1087.
65. Rollene, N.L., Amols, M.H., Hudson, S.B., & Coddington, C.C. (2009). Treatment of ovarian hyperstimulation syndrome using a dopamine agonist and gonadotropin releasing hormone antagonist: a case series. Fertility and Sterility, 92, 1169.e15-17.
66. Shrivastav, P., Nadkarni, P., & Craft, I. (1994). Day care management of severe ovarian hyperstimulation syndrome avoids hospitalization and morbidity. Human Reproduction, 9, 812-814. (Pubitemid 24168063)
67. Shukla, U., Deval, B., Hamoda, H., Savvas, M., & Narvekar, N. (2011). A programme of outpatient surveillance for women at risk of severe OHSS following IVF: A prospective follow-up review of 99 cases. Human Fertility, 14, No. S1 : 7.
68. Simoni, M., Tempfer, C.B., Destenaves, B., & Fauser, B.C.J.M. (2008). Functional genetic polymorphisms and female reproductive disorders: Part 1: polycystic ovary syndrome and ovarian response. Human Reproduction, 14, 459-484.
69. Smith, L.P., Hacker, M.R., & Alper, M.M. (2009). Patients with severe ovarian hyperstimulation syndrome can be managed safely with aggressive outpatient transvaginal paracentesis. Fertility and Sterility, 92, 1953-1959.
70. Smits, G., Olatunbosun, O., Delbaere, A., Pierson, R., Vassart, G., & Costagliola, S. (2003). Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. New England Journal of Medicine, 349, 760-766. (Pubitemid 37010780)
71. Strandvik, G.F. (2009). Hypertonic saline in critical care: a review of the literature and guidelines for use in hypotensive states and raised intracranial pressure. Anaesthesia, 64, 990-1003.
72. Tan, T.S., Tan, K.H., Ng, H.P., & Loh, M.W. (2002). Th e eff ects of hypertonic saline solution (7.5%) on coagulation and fi brinolysis: an in vitro assessment using thromboelastography. Anaesthesia, 57, 644-648. (Pubitemid 34732507)
73. Teruel, M.J., Carbonell, L.F., Teruel, M.G., Parrilla, J.J., Abad, L., & Hernandez, I. (2001). Eff ect of angiotensin-converting enzyme inhibitor on renal function in ovarian hyperstimulation syndrome in the rabbit. Fertility and Sterility, 76, 1232-1237. (Pubitemid 33116392)
74. Teruel, M.J., Carbonell, L.F., Llanos, M.C., Parrilla, J.J., Abad, L., & Hernandez, I. (2002). Hemodynamic state and the role of angiotensin II in ovarian hyperstimulation syndrome in the rabbit. Fertility and Sterility, 77, 1256-1260. (Pubitemid 34626338)
75. Tollan, A., Holst, N., Forsdahl, F., Fadnes, H.O., Oian, P., & Maltau, J.M. (1990). Transcapillary fl uid dynamics during ovarian stimulation for in vitro fertilization. American Journal of Obstetrics & Gynecology, 162, 554-558. (Pubitemid 20068539)
76. Vardhana, P.A., Julius, M.A., Pollak, S.V., Lustbader, E.G., Trousdale, R.K., & Lustbader, J.W. (2009). A unique human chorionic gonadotropin antagonist suppresses ovarian hyperstimulation syndrome in rats. Endocrinology, 150, 3807-3814.
77. Warren, R.S., Yuan, H., Matli, M.R., Ferrara, N., & Donner, D.B. (1996). Induction of vascular endothelial growth factor by insulin-like growth factor I in colorectal carcinoma. Journal of Biological Chemistry, 271, 483-488.
78. Whelan, J.G. III. & Vlahos, N.F. (2000). The ovarian hyperstimulation syndrome. Fertility and Sterility, 73, 883-896. (Pubitemid 30227510)
79. Zosmer, A., Katz, Z., Lancet, M., Konichezky, S., & Schwartz-Shoham, Z. (1987). Adult respiratory distress syndrome complicating ovarian hyperstimulation syndrome. Fertility and Sterility, 47, 524-526. (Pubitemid 17054232)